Health & Personal Care
HIGH
FDA DRUG
Pfizer Recalling Levoxyl Due to Subpotent Drug Hazard
Pfizer Inc. recalled 29,004 bottles of Levoxyl on July 29, 2025, due to subpotency. The recall affects levothyroxine sodium tablets, 50 mcg, Rx only, distributed in the U.S. Consumers should stop using the product immediately.
Levoxyl
Subpotent drug